In this study we assessed whether low density lipoproteins (LDL) isolated from minced aortic atherosclerotic plaques obtained at autopsy (A-LDL) shared structural and functional properties with LDL oxidized by incubation with Cu 2+ for 8-18 hours at 20°C (Ox-LDL). Although both A-LDL and Ox-LDL represented monomeric particles about the size of LDL, both differed from LDL in that they showed an increase in electrophoretic mobility relative to LDL, an increase in cholesterol to protein ratio, and an increase in reactivity with a monoclonal antibody that recognizes epitopes on malondialdehyde (MDA)-modified proteins. In addition, both showed an increase in fluorescence at 360 nm excitation, 430 nm emission, an increase in fragmentation of apolipoprotein B with patterns that were quite similar, and an increase in recognition by the scavenger receptor on mouse peritoneal macrophages (MPMs) based on competition of bation of LDL with macrophages does not lead to lipid loading 7 because the receptor responsible for internalizing LDL, the LDL receptor, is downregulated by increases in intracellular cholesterol content. 8 However, specific chemical modification of LDL, such as acetylation or interaction with malondialdehyde (MDA), leads to LDL uptake by macrophages via a high-affinity binding site that has been designated the scavenger receptor. 7 We have previously demonstrated that LDL isolated from human atherosclerotic lesions (A-LDL) is taken up more avidly by mouse peritoneal macrophages (MPMs) than is plasma LDL and that this leads to lipid loading of these cells. 910 However, the underlying mechanism responsible has not been elucidated.
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In this study we assessed whether low density lipoproteins (LDL) isolated from minced aortic atherosclerotic plaques obtained at autopsy (A-LDL) shared structural and functional properties with LDL oxidized by incubation with Cu 2+ for 8-18 hours at 20°C (Ox-LDL). Although both A-LDL and Ox-LDL represented monomeric particles about the size of LDL, both differed from LDL in that they showed an increase in electrophoretic mobility relative to LDL, an increase in cholesterol to protein ratio, and an increase in reactivity with a monoclonal antibody that recognizes epitopes on malondialdehyde (MDA)-modified proteins. In addition, both showed an increase in fluorescence at 360 nm excitation, 430 nm emission, an increase in fragmentation of apolipoprotein B with patterns that were quite similar, and an increase in recognition by the scavenger receptor on mouse peritoneal macrophages (MPMs) based on competition of 125 
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I-Ox-LDL degradation by excess acetylated LDL. In addition, inhibition of degradation by MPMs of
I25 I-A-LDL and 125 I-Ox-LDL by excess unlabeled Ox-LDL and A-LDL were similar. When MDA was added in increasing amounts to labeled LDL and A-LDL, less MDA was required to modify A-LDL than LDL to obtain ligands that were degraded by MPMs to the same degree. Finally, both A-LDL and Ox-LDL but not LDL underwent aggregation (increased metastability) when concentrated to levels exceeding 1 mg protein/ml and showed enhanced macrophage uptake via phagocytosis (inhibition by cytochalasin D). These results demonstrate that A-LDL and Ox-LDL share properties additional to those previously reported, suggesting that oxidation may be a major mode of modification of LDL accumulating in atherosclerotic lesions. This could lead to lipid loading of macrophages induced by phagocytosis of aggregated particles, in addition to unregulated uptake via the scavenger receptor of monomeric particles. (Arteriosclerosis and Thrombosis 1991;ll:1209-1222) T he fatty streak lesion is generally considered to be the initial atherosclerotic lesion. 1 Its hallmark is the lipid-laden macrophage, or foam cell. 1 The macrophages are believed to be derived from blood monocytes. 2 Plasma low density lipoprotein (LDL) can accumulate to high levels in grossly normal arteries 34 and in advanced atherosclerotic lesions. 56 Tissue macrophage uptake of this accumulated LDL is suggested to be the mechanism by which such macrophage-derived foam cells are formed. 1 -7 However, under in vitro conditions incu-bation of LDL with macrophages does not lead to lipid loading 7 because the receptor responsible for internalizing LDL, the LDL receptor, is downregulated by increases in intracellular cholesterol content. 8 However, specific chemical modification of LDL, such as acetylation or interaction with malondialdehyde (MDA), leads to LDL uptake by macrophages via a high-affinity binding site that has been designated the scavenger receptor. 7 We have previously demonstrated that LDL isolated from human atherosclerotic lesions (A-LDL) is taken up more avidly by mouse peritoneal macrophages (MPMs) than is plasma LDL and that this leads to lipid loading of these cells. 910 However, the underlying mechanism responsible has not been elucidated.
Oxidation of LDL results in recognition of LDL by the scavenger receptor on macrophages, 1112 a process that is not regulated by cellular cholesterol content. 7 Thus, if A-LDL in part represents oxidized (Ox-) LDL, then this might explain the ability of A-LDL to induce lipid loading of macrophages. The aim of this current study was, therefore, to assess whether A-LDL is oxidized. We have compared A-LDL and Ox-LDL prepared by incubation with Cu 2+ ions, with respect to several chemical and structural properties and their interactions with macrophages in culture. A-LDL and Ox-LDL were shown to share numerous structural and functional characteristics, suggesting that one of the modifications found in A-LDL is oxidation.
Methods
Cells and Reagents
C57BL/6 mice (9-12 weeks of age) were purchased from the Trudeau Institute, Saranac Lake, N.Y. RPMI medium and fetal calf serum were obtained from GIBCO Laboratories, Grand Island, N.Y. Bovine serum albumin (BSA; fatty-acid free), gentamicin, leupeptin, pepstatin, aprotinin, polyethylene glycol (20,000), and vitamin E were purchased from Sigma Chemical Co., St. Louis, Mo. Tissue-culture plates were from Costar, Cambridge, Mass. Carrierfree [ 125 I]NaI was purchased from ICN Pharmaceuticals, Inc., Irvine, Calif. Goat anti-human LDL, goat anti-mouse immunoglobulin G (IgG), goat nonimmune sera, rabbit anti-goat IgG, and mouse nonimmune sera were purchased from Bethyl Laboratories, Montgomery, Tex. Precast 1% agarose gels were purchased from Corning, Palo Alto, Calif. Nitrocellulose membranes were obtained from Schleicher and Schuell, Keene, N.H. Sephacryl 400 (HR) was obtained from Pharmacia-LKB Biotech Inc., Piscataway, N.J. Centriprep 30 concentrators were purchased from Amicon Corp., Danvers, Mass. Spectra/ Por 2 and 3 dialysis tubing was obtained from Spectrum Medical Industries Inc., Los Angeles, Calif. Af-a-carbobenzoxyl-L-lysine was purchased from Aldrich Chemical Co., Milwaukee, Wis.
Isolation of Plasma Low Density Lipoproteins, Their Iodination, and Chemical Modification
LDL was isolated from fresh plasma (obtained from the American Red Cross Blood Services of Cleveland or the Cleveland Clinic Blood Bank) by sequential ultracentrifugation as a 1.019<d< 1.063 g/ml fraction by use of the procedure of Hatch and Lees 13 and was stored in 0.15 M NaCl containing 0.5 mM EDTA, pH 8.5, and in select cases, in 0.15 M NaCl, 0.3 M EDTA, pH 7.4. LDL was acetylated by repetitive additions of acetic anhydride 14 and then extensively dialyzed against 0.15 M NaCl, 0.3 mM EDTA, pH 7.4. The extent of lysine modification, measured by changes in 2,4,6-trinitrobenzenesulfonic acid (TNBS) reactivity 15 with 7V-a-carbobenzoxy-L-lysine as a standard, usually exceeded 60% of the lysyl residues on LDL. LDL and acetylated (Acetyl-) LDL were labeled for cell experiments with 125 I by the iodine monochloride procedure of McFarlane, 16 as modified by Bilheimer et al 17 ; the specific activity of labeled preparations was generally about 100-200 cpm/ng protein. Lipoprotein concentrations were routinely expressed as micrograms protein per milliliter. LDL at concentrations between 100 ng and 2 mg protein/ml was oxidized by dialysis against 10 /xM CuSO 4 for 8-18 hours at 20°C. MDA was prepared and used to modify LDL at pH 6.4, as described previously. 18 LDL was reductively methylated according to the procedure of Weisgraber et al. 19 
Isolation of Low Density Lipoproteins Extracted From Human Atherosclerotic Lesions
Human aortas with advanced atherosclerotic plaques (fibrous plaques and complicated lesions) were obtained at autopsy within 12 hours of death. The tunica intima was mechanically stripped from the underlying tunica media at a natural cleavage plane formed at the internal elastic membrane, rinsed briefly in 0.15 M NaCl, 0.1 M NaH 2 PO 4 , pH 7.4, or phosphate-buffered saline (PBS), also containing 1.5 mM EDTA, 5 fjM leupeptin, 35 fiM pepstatin, 50 /xg/ml gentamicin, 100,000 IU/ml aprotinin, and 20 fiM vitamin E to remove any adhering blood constituents, and finely minced as described previously. 356 Tissue minces were added to this PBS at a tissue mass to volume ratio of 0.2. The tissue minces were incubated in this PBS for 18 hours at 4°C. The resulting suspensions were then centrifuged at 25,000g for 1 hour at 4°C, and the supernatant was filtered through glass wool that removed any large lipid droplets from the suspension. The solvent density of the filtered fraction was then adjusted to d=1.10 g/ml with NaBr, and the mixture was ultracentrifuged for 18 hours at 260,000g at 4°C. The floated fraction was removed, dialyzed against PBS as described above, except that PBS contained EDTA at 0.3 mM, and then subjected to gelexclusion chromatography on a Sephacryl 400 HR column (dimensions 87x1.5 cm) at a flow rate of 1 ml/min. In selected cases, 125 I-LDL was added to the plaque isolate before chromatography to compare the elution of LDL in tissue and plasma. In addition to measuring the protein in each tube, we also monitored immunoreactive apolipoprotein (apo) B by a radioimmunoassay. A retained fraction from the column that essentially coeluted with LDL and contained 50-70% of the total immunoreactivity applied to the column was pooled and designated A-LDL. A more detailed description of the isolation procedures and recoveries has recently been published elsewhere. 20 A total of 20 separate samples of A-LDL were obtained, each from a separate individual. A-LDL was subjected to iodination as described above 1617 after dialysis to remove unbound vitamin E from the solution, as vitamin E inhibited the iodination step. Modification of A-LDL with MDA was performed as described for LDL. 18 Pigeon arterial proteoglycan, rich in chondrotin sulfate and supplied by William Wagner, Bowman Gray School of Medicine, was isolated according to his published procedure. 21 
Procedures Performed on Lipoproteins
The protein content of lipoproteins was determined by the bicinchoninic acid assay, as described by Smith et al, 22 except that a 60-minute, 60°C heating step was used. BSA was employed as a standard. This technique was used because of its greater sensitivity than that of Lowry et al. 23 However, this technique consistently gave values 30% higher than those obtained by the technique of Lowry et al, 23 but the latter values were more consistent with independent molecular weight estimates. Therefore, we shifted all our protein determinations to those obtained by the Lowry procedure by dividing all bicinchoninic acid protein values by 1.3. Cholesterol content was determined by a modification of the procedure of Roeschlau et al 24 by use of a reagent kit from Boehringer-Mannheim, Indianapolis, Ind. Lipoprotein morphology was determined by transmission electron microscopy with phosphotungstic acid as a negative stain. 25 Mean diameters of A-LDL and LDL particles were obtained by measuring the diameters of 200 particles per sample in electron photomicrographs. The electrophoretic mobility of lipoproteins was determined by agarose electrophoresis at 90 V for 75 minutes by using precast 1% agarose gels, following the manufacturer's instructions, and staining with 0.025% Fat Red 7B in 60% methanol. The protein components of reduced, denatured, and delipidated lipoproteins were evaluated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with a 3-8% acrylamide gradient 26 and diacrylylpiperazine (Integrated Separation Systems, Hyde Park, Mass.) as a cross-linker. After overnight fixing of the acrylamide gels in 50% methanol, proteins were stained with Daiichi 2-D silver stain (Tokyo, Japan) according to the manufacturer's instructions, or 125 I-labeled apolipoproteins were detected by autoradiography by use of an X-omatic cassette with K film (Kodak, Rochester, N.Y.). The degree of oxidation of A-LDL or Ox-LDL was estimated by measuring its fluorescence at 360 nm excitation, 430 nm emission by use of a PerkinElmer Fluorimeter (model LS-3, Oak Brook, 111.), as reported earlier, 27 but with a concentration of 50 fig protein/ml and after adjustment for the background fluorescence of the PBS buffer.
In select cases 125 I-labeled lipoproteins were subjected to concentration by use of a Centriprep 30 concentrator or to concentration dialysis by use of Spectra/Por 3 dialysis tubing (3,500 molecular-weight cutoff) and polyethylene glycol (20,000 molecular weight). The concentrated solutions were then centrifuged at 10,000g for 10 minutes, and the amount of label that could be precipitated was used as an estimate of lipoprotein aggregation.
Complexes between LDL and pigeon arterial proteoglycan were formed by the previously described procedure. 21 In brief, 500 fig LDL was 28 LDL was also incubated with lipoproteindeficient serum at an LDL protein to plasma protein ratio of 1:3. The fluorescence emission at 360 nm excitation was then determined for the individual samples for LDL at 50 fig protein/ml and for the mixture containing LDL at 50 /xg/ml.
Determination of the Presence of Epitopes Unique for Malondialdehyde-Modified Proteins in Lipoproteins
A procedure using a slot-blot apparatus purchased from Biorad, Richmond, Calif., was used to determine cross-reactivity between A-LDL or Ox-LDL and epitopes on MDA-modified proteins by use of a monoclonal antibody directed at epitopes on MDA-LDL (MDA 2-4C5-1H4) prepared as previously described. 29 Briefly, 0-3 fig lipoproteins was applied to nitrocellulose membranes (0.45-/im pore size) that were subsequently blocked by incubation with 5% BSA in PBS containing 0.02% KC1 and 10 mM NaN 3 for 2 hours at 37°C. Membranes were then incubated for 24 hours at 4°C with a 1:20,000 dilution of the MDA-2 monoclonal antibody in 1.6% NaCl, 0.1% BSA, and 1% nonimmune goat serum. After the membranes were washed three times for 5 minutes at 37°C with PBS containing 0.1% BSA, they were incubated for 24 hours at 4°C with 125 I-goat anti-mouse IgG at a 1:1,600 dilution. After further washing as described above, the membranes were cut and counted.
Lipoprotein Interactions With Macrophages in Culture
MPMs were harvested 2-3 days after thioglycollate stimulation of C57BL/6 mice, and primary cultures were prepared at a density of 10 6 cells/16 -mmdiameter well and used 48 hours after plating. Cells were incubated at 37°C in 95% air, 5% CO 2 for 48 hours in RPMI medium containing 5% fetal calf serum. The uptake and subsequent degradation of 125 I-lipoproteins by macrophages were measured as described previously. 1014 Briefly, the cells were incubated in triplicate with 125 I-labeled lipoproteins with or without excess unlabeled competing lipoproteins in RPMI containing 6 mg/ml BSA. The extent of degradation was determined as the amount of trichloroacetic acid (TCA)-soluble noniodide radioactivity present in the media. Radioactivity in cell-free control wells was routinely determined for each condition and subtracted from that obtained in the presence of cells. Degradation was expressed as the mean amount of micrograms protein degraded per milligram cell protein per 4.5-hour incubation period ±SD. The experiments described were representative of two or more studies. Cytochalasin D, an inhibitor of phagocytosis, 30 was prepared as a 2 mg/ml solution in dimethyl sulfoxide and added to cells at a final concentration of 4 figlrcA. Dimethyl sulfoxide was added alone in a separate study to test by guest on July 11, 2017 http://atvb.ahajournals.org/ Downloaded from P P F P P P P P r P r r 
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the effect of the vehicle. In preliminary studies we found that dimethyl sulfoxide at concentrations of 0.5% or less of the total volume had no effect on degradation levels.
Results
Structural and Chemical Characteristics of Low Density Lipoproteins Extracted From Human Atherosclerotic Lesions and Oxidized Low Density Lipoproteins
When A-LDL, as isolated by the procedures described in the "Methods" section, was viewed with an electron microscope, particles were observed that were slightly larger than those of plasma LDL (Figure 1 , upper panels) and that were more heterogeneous in size ( Figure 1 , lower panel). Ox-LDL prepared by dialyzing LDL in the presence of 10 CuSO 4 for 8 hours also consisted of monomeric particles (not shown). Relative to plasma LDL, both A-LDL and Ox-LDL demonstrated increases in electrophoretic mobility, cholesterol to protein ratio, and fluorescence at 360 nm excitation, 430 nm emission (Table 1 ). This fluorescence is characteristic of Schiff-base adducts formed between aldehydic products of lipid peroxidation and lysine residues on apo B. 27 When the emission spectrum was determined for A-LDL and Ox-LDL over the 400-500 nm range, they were found to be essentially the same (Figure 2) .
In a separate study we assessed whether interaction of LDL with extracts of human atherosclerotic plaques for 2 hours at 37°C at an LDL protein to lipoprotein-deficient serum protein ratio of 1:4.5 would induce similar changes in fluorescence properties as were found in A-LDL and Ox-LDL. No (6) Low density lipoproteins extracted from atherosclerotic lesions (A-LDL), oxidized low density lipoproteins (Ox-LDL), and LDL were isolated as described in "Methods." Electrophoretic mobility of lipoproteins relative to that of LDL (REM), fluorescence of lipoproteins at a protein concentration of 50 /ig/ml after adjustment for background fluorescence of the buffer, and cholesterol and protein measurements of lipoproteins were determined as described in "Methods." Values represent mean±SD of the number of measured samples (n). 360 ex/430 em, 360 nm excitation/430 nm emission.
increases in fluorescence emission between 400 and 500 nm were detected in such LDL (not shown). Likewise, no increases in LDL fluorescence were detected when LDL was mixed with lipoproteindeficient serum at an LDL protein to lipoproteindeficient serum protein ratio of 1:3, suggesting that interaction of LDL with plasma proteins also failed to increase the fluorescence of LDL between 400 and 500 nm. Finally, pigeon arterial proteoglycan, as well as complexes of LDL with proteoglycan prepared as described in "Methods," also failed to demonstrate the increases in emission fluorescence between 400 and 500 nm that are characteristic of A-LDL and Ox-LDL (not shown).
Another characteristic of A-LDL also seen in Ox-LDL 31 was fragmentation of apo B-100, as demonstrated by SDS-PAGE with use of a 3-8% acrylamide gradient (Figure 3 ). Such fragmentation was seen either when unlabeled A-LDL and Ox-LDL were stained with silver or when Recently, antibodies that recognize epitopes on MDA-modified LDL 29 have been found to react positively with samples of LDL extracted from aortic lesions derived from Watanabe heritable hyperlipidemic rabbits 3233 and from human transplant donors. 33 Using a monoclonal antibody shown to recognize MDA-protein adducts (MDA 2-04 CS-144), 29 -32 we found that both A-LDL and Ox-LDL interacted with this antibody in a concentration-dependent fashion (Figure 4) . By contrast, unmodified LDL to which butylated hydroxytoluene was added showed no reactivity. LDL modified with MDA, as previously reported, 29 showed high reactivity.
Interaction of Low Density Lipoproteins Extracted From Human Atherosclerotic Lesions and Oxidized Low Density Lipoproteins With Macrophages
When MPM degradation was measured in six individual samples of 125 I-A-LDL, the levels ranged from 0.2 to 1.9 /ig protein degraded/mg cell protein/ 4.5-hr incubation period. Although some of this variability could be attributable to metabolic differences in individual primary cultures of MPMs as determined by 125 I-Acetyl-LDL and 125 I-LDL degradation levels, most of the variability appeared to be a function of the individual samples of A-LDL themselves. We had recently shown that no major structural and functional differences could be detected between A-LDL samples isolated from arteries obtained at autopsy within 12 hours after death and those obtained immediately at surgery. 20 Because in earlier studies Ox-LDL had been shown to be recognized by the scavenger receptor on macrophages, 1112 we tested whether the degradation of In preliminary studies we had found that (Figure 5 ), suggesting that the inhibition by LDL, albeit low, was probably due to the LDL receptor. These results suggest that uptake of A-LDL and Ox-LDL may be induced by other mechanisms in addition to the scavenger receptor.
To show that MPM degradation levels in the presence and absence of unlabeled ligands were not the result of extracellular proteases secreted by MPMs, we incubated 125 I-A-LDL for 4.5 hours at 37°C with conditioned media derived from MPMs previously incubated for 4.5 hours in the presence or absence of unlabeled Acetyl-LDL or Ox-LDL. No increase in TCA-soluble label was found under any of the conditions used (not shown), suggesting that lipoprotein degradation was not due to digestion by proteases released by MPMs. 
FIGURE 4. Line plot of slot-blot analysis of specific binding of LDL extracted from human atherosclerotic lesions (-O-), oxidized LDL (-•-), LDL isolated in the presence ofbutylated hydroxytoluene (-D-), and malondialdehyde (MDA)-modified LDL (-A-) to a monoclonal antibody directed at epitopes on MDA-modified LDL (MDA-2-4C5-1H4). Slots on nitrocellulose sheets were treated sequentially with lipoproteins (0-3 fig protein), 0.1% bovine serum albumin to block sites, monoclonal antibody to MDA-LDL (1:20,000 dilution), and
125
Igoat-antimouse immunoglobulin G (1:1,600). Washes between each step were performed as described in "Methods." Amount of specific label present in each well was determined after subtracting the nonspecific level (determined by applying nonimmune mouse serum instead of monoclonal antibody) from the total amount of label.
Modification of LDL with MDA, an aldehydic product of lipid peroxidation, 27 had been shown to block lysine residues on apo B, which in turn resulted in its recognition by the scavenger receptor on macrophages when more than 16% of the lysine residues on apo B were blocked. 18 We surmised that if lysine residues on apo B in A-LDL had already been blocked due to oxidation, less modification with MDA would be needed than for a corresponding sample of LDL to obtain ligands with equal degradation rates in MPMs. Samples of Figure 6, upper panel) , similar to what had previously been shown by Haberland et al, 18 but with a more shallow slope.
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I-A-LDL immediately showed a gradual but consistent increase in MPM degradation with increasing degrees of modification with MDA and with a slope that paralleled that of MDA-modified LDL at higher levels of modification with MDA. However, about 10 mM less MDA was required to modify A-LDL than LDL to obtain equivalent levels of MPM degradation ( 
FIGURE 5. Line plots showing degradation by mouse peritoneal macrophages (MPMs) of 125 I-LDL extracted from human atherosclerotic lesions (A-LDL) (left panel) and I25 I oxidized (Ox-) LDL (right panel) in the absence and presence of increasing amounts of unlabeled LDL (•), methylated LDL (A), acetylated (Acetyl) LDL (•), and Ox-LDL
mM MDA added
MDA added of 12%, 51%, 76%, 95%, and 93% for LDL, and of 64%, 74%, 86%, 88%, and 86%, for A-LDL. This strongly suggests that for this specific sample of A-LDL, most MPM uptake of both the original and MDA-modified forms was mediated by the scavenger receptor. However, in other samples of A-LDL not treated with MDA, inhibition of degradation by excess Acetyl-LDL was not as complete (not shown).
We had originally attempted to ascertain blockage of lysine residues on apo B in A-LDL by use of the TNBS assay. However, the results indicated that more free amino groups were present than in LDL (not shown). We speculate that a-amino groups liberated by the fragmentation of apo B in A-LDL reacted in the assay, thus overestimating the number of e-amino groups in apo B from A-LDL. Although the number of e-amino groups blocked in A-LDL was not directly measured, we estimated the blockage of such groups by incremental amounts of MDA added to A-LDL and LDL. This was achieved by first documenting the relation between amounts of MDA added and increases in particle relative electrophoretic mobility for both A-LDL and LDL and for that between electrophoretic mobility relative to LDL and blockage of lysine residues in LDL by use of the TNBS assay. Linear relations were found for each, and the line for the electrophoretic mobility relative to LDL versus amount of MDA added for A-LDL roughly paralleled that for LDL ( Figure 6 , lower panel). The percentage of lysines blocked was about 15% at the inflection point at which macrophage uptake and degradation of LDL and A-LDL began to increase, which was about the level found by Haberland et al 18 in human monocyte-macrophages. However, the slope of this curve was much more shallow than that in the published study, 18 perhaps attributable to differences in the two types of macrophages.
Metastability of Low Density Lipoproteins Extracted From Human Atherosclerotic Lesions and Oxidized Low Density Lipoproteins
In preliminary studies we noted that A-LDL demonstrated a metastability that manifested itself in a tendency to self-aggregate. One way that such selfaggregation could be induced was by subjecting samples of A-LDL to a concentration procedure, with final concentrations of approximately 1-2 mg/ml. Such concentration-induced aggregation occurred to an equal degree when a Centriprep 30 concentrator or dialysis against polyethylene glycol was used (not shown). To assess whether such metastability of A-LDL toward a concentration step was also a characteristic of Ox-LDL, we compared the ability of A-LDL, Ox-LDL, and LDL to undergo aggregation after a 20-fold concentration step from 100 fig protein/ml to 2 mg protein/ml. Aggregation was estimated by the percentage of 125 I-lipoprotein that could be precipitated by centrifugation at 10,000g. Aggregation before and after concentration rose from less than 5% to 20% for A-LDL, from 10% to 26% for Ox-LDL, and from less than 5% to less than 5% for LDL. Thus, A-LDL and Ox-LDL but not LDL demonstrated this metastability. The level of aggregation estimated by the percent of label precipitated by centrifugation is probably an underestimate. Recovery of A-LDL and Ox-LDL during the concentration step was 20-40% poorer than that of LDL; that is, aggregates presumably adhered to the dialysis tubing and could not be recovered by washing. As expected, centrifuged precipitates of concentrated A-LDL represented the complexing of a vast number of monomeric particles (Figure 7, left panel) . However, even the supernatant fraction of centrifuged samples of concentrated A-LDL contained aggregates, albeit smaller ones (Figure 7 , right panel), suggesting that total particle aggregation exceeded that measured by precipitation by low-speed centrifugation. This aggregation appeared to be irreversible because redilution of concentrated samples of A-LDL still contained the same percentage of label that could be precipitated by centrifugation as that in undiluted samples (not shown).
To assess whether the metastability of A-LDL and Ox-LDL affected their recognition by MPMs, we compared the degradation of I-Ox-LDL was found after concentration, which led to a 16% increase in the percentage of label that was precipitated. By contrast, 125 I-LDL, which could not be induced to precipitate by concentration, showed no increase in degradation. Thus, the metastability found in A-LDL and Ox-LDL also resulted in enhanced uptake and degradation by MPMs.
When another sample of 125 I-A-LDL was concentrated fivefold, causing 28% of the label to precipitate after centrifugation, the concentrated sample demonstrated about a fivefold increase in MPM degradation compared with that of the original unconcentrated sample when applied to cells at equal concentrations ( Figure 9 ). When equal concentrations of the precipitated fraction and its corresponding supernatant fraction were incubated with MPMs, the precipitated fraction was degraded 10-fold greater than the original sample. The supernatant sample still showed almost a doubling in MPM degradation compared with that of the original unconcentrated sample (Figure 9) .
One possible reason for enhanced uptake of aggregated %-A-LDL or fraction by only 26%. The vehicle for cytochalasin, dimethyl sulfoxide, at a concentration of 0.5% vol/vol or less, was shown in control studies not to have any effect on degradation (not shown).
Discussion
In addition to confirming a number of previously reported structural and functional characteristics shared by A-LDL and Ox-LDL, we documented several additional characteristics shared between them that have not yet been published. These are 1) the increase in fluorescence at 430 nm emission, 360 nm excitation, 2) the similarity in banding patterns in fragmented apo B, 3) the functional characteristics after further modification with MDA, and 4) the metastability manifested by an increased tendency to aggregate when subjected to concentration steps and the resultant increase in MPM degradation. Although we cannot completely exclude the possibility that some of the altered characteristics of A-LDL may have been caused by types of modification other than oxidation, the strong circumstantial data provided in this study seem compelling. A-LDL isolated from atherosclerotic lesions derived from humans or Watanabe heritable hyperlipidemic rabbits has been previously shown by us and others to share several structural characteristics with Ox-LDL. These are increases in electrophoretic mobility relative to LDL 35 -38 and in thiobarbituric acid-reactive substances, 39 fragmentation of apo B, two major propagation products of lipid peroxidation. 274041 Because such epitopes in aldehyde-modified LDL and Ox-LDL were also detected immunohistochemically in tissue sections, 323342 - 44 it is unlikely that the presence of such epitopes in A-LDL is an artifact of the isolation procedure. Increases in fluorescence at 360 nm excitation, 430 nm emission found by us in this study were previously documented for Ox-LDL 27 and 4-hydroxynonenal-modified LDL. 40 - 41 The reproducible pattern for apo B fragmentation products on SDS-PAGE found by us in separate samples of A-LDL and Ox-LDL is consistent with results obtained by Fong et al, 30 who showed a similar banding pattern of apo B fragments in Ox-LDL. The increase in the cholesterol to protein ratios in A-LDL and Ox-LDL relative to that for LDL found in this study is consistent with data on A-LDL previously published by us 9 and others 33 but is inconsistent with a previously published study on this ratio in Ox-LDL, which was shown to decrease. 45 These discrepancies noted above may reflect a different degree of oxidation in the earlier reports than in the present study.
It was previously shown in one study that A-LDL isolated from human lesions is recognized by the scavenger receptor on MPMs, that is, by competition with excess Acetyl-LDL. 38 This was confirmed and extended by data in the present study, which demonstrated not only that excess Acetyl-LDL and excess Ox-LDL were potent inhibitors of 125 I-A-LDL degradation but also that less MDA was required to modify A-LDL than LDL to obtain ligands with similar degradation rates in MPMs. Although this latter result does not exclude alternative types of modification in A-LDL that could have been responsible for enhanced macrophage recognition, it is consistent with some prior modification of A-LDL with aldehydic products of lipid peroxidation, resulting in blockage of lysine residues equivalent to the LDL modified by 8 mM MDA, as shown in Figure 6 , upper panel. However, it should be stressed that recognition of A-LDL by the scavenger receptor on macrophages, as assessed by inhibition of I-A-LDL uptake and degradation by excess Acetyl-LDL or MDA-LDL, was found by us to be highly variable in this study or to be completely lacking in an earlier study. 10 This also appears to be the case in one published study in which two separate samples showed different inhibitions to excess MDA-modified LDL and to Acetyl-LDL. 33 Whether biologic variability is solely responsible or whether procedural factors played a role still needs to be determined. Biologic variability could reflect differences in the number of particles in different batches of A-LDL that underwent sufficient modification by oxidation to render these particles recognizable by the scavenger receptor.
The similarity in the degree of cross-competition in MPM degradation found by us for Acetyl-LDL and Ox-LDL is not consistent with a recent report in which excess unlabeled Ox-LDL was found to be a far better competitor for the degradation of 125 I-Ox-LDL than was excess Acetyl-LDL, whereas Ox-LDL was as good a competitor as Acetyl-LDL for the degradation of 125 I-Acetyl LDL. 46 Perhaps the degree of oxidation of LDL influences recognition of Ox-LDL by a novel receptor, as proposed by Sparrow et al. 46 The observation made by us in this study, that both A-LDL and Ox-LDL but not LDL can be induced to aggregate by a concentration step, had not been reported earlier, although MDA-modified LDL and Ox-LDL had been shown to undergo aggregation after incubation with culture medium, 47 and Yokode et al 48 had reported that Ox-LDL contained larger particles than did LDL. Khoo et al 49 showed that the mechanical manipulation of vortexing also induced LDL particle aggregation. This resulted in increased MPM uptake by phagocytosis, as we had found for aggregates of A-LDL and Ox-LDL. They further found that this aggregation could be inhibited by apolipoproteins with amphipathic properties, such as apo A-I and apo E, 50 and that this inhibition was due to the prevention of interactions between hydrophobic regions on apo B in separate particles that became exposed by mechanical disruption.
Several lines of circumstantial evidence suggest that aggregation of some A-LDL could occur in human atherosclerotic lesions: 1) Only about 50% of immunoreactive apo B could be extracted from human lesions with conventional buffers. 56 The remain-ing fraction was liberated by detergents or enzymes that digested the residual plaque tissue. 5 Although tight binding of LDL to plaque components is the most likely reason for this result, formation of selfaggregates that are insoluble in a conventional buffer certainly is another possibility. 2) About one half of the immunoreactive apo B extracted from human plaque homogenates by a conventional buffer did not coelute with LDL by gel exclusion chromatography and was present in the void volume fraction. 9 This fraction was avidly internalized by MPMs. 9 3) Immunoperoxidase studies at the electron microscopic level performed by us 5152 also demonstrated the presence of spherical structures about the size of LDL, with surfaces that were decorated with peroxidase reaction product, that is, they were immunopositive for apo B. Many of these particles were closely packed, giving the same ultrastructural morphology as large aggregates of A-LDL seen in the current study by the use of negative staining. 4 53 demonstrated the presence of particles resembling aggregated and/or coalesced LDL particles in the aortic intima of Watanabe heritable hyperlipidemic and cholesterol-fed rabbits by freeze-etching techniques. Thus, the observations that both monomeric A-LDL and Ox-LDL undergo aggregation in vitro when present at high concentrations is compatible with the argument that some A-LDL may be in an aggregated state when present focally at high concentrations in atherosclerotic lesions.
The mechanism responsible for such aggregation may be exposure of hydrophobic groups on Ox-LDL or A-LDL that induces irreversible self-association when interparticle distances are short, as proposed by Khoo et al 50 for vortexed LDL. However, it may also be due to interparticle cross-linking by bifunctional aldehydes such as the 4-hydroxynonenal produced during lipid peroxidation. 4041 We have demonstrated that when LDL at a concentration of 500 fig protein/ml is modified sufficiently with 4-hydroxynonenal, it undergoes massive irreversible aggregation. 54 Apo B from such aggregated particles appeared to be cross-linked, as only one half of the apo B entered a 3-12% acrylamide gel during SDS-PAGE. 54 Intermolecular cross-linking by aldehydes after a concentration step implies that free reactive groups are available or became available at times appreciably after the oxidative modification. This assumption still needs to be verified. Furthermore, we found that aggregated 4-hydroxynonenal-modified LDL, like concentrated Ox-LDL and A-LDL, was taken up and degraded more avidly than was LDL and that uptake was mediated by phagocytosis. 54 In summary, this study demonstrates several structural and functional similarities between A-LDL and Ox-LDL. Some results confirm other published observations, that is, electrophoretic mobility relative to LDL, cholesterol to protein ratios, interaction with monoclonal antibodies recognizing MDA-protein adducts, similarity in the banding pattern of fragmented apo B on SDS-PAGE, and scavenger receptor recognition. Others, such as the increased fluorescence at 360 nm excitation, 430 nm emission, the modification of A-LDL and LDL with MDA, and the metastability of both A-LDL and Ox-LDL to aggregation after concentration and the subsequent increase in MPM degradation after phagocytosis, are all new findings. Our study suggests that oxidation may be responsible for at least two uptake mechanisms by MPM, that is, the scavenger receptor for monomeric particles and phagocytosis for aggregated particles. However, other forms of modification leading to other uptake mechanisms may also be operative.
